Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chouaib

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Oncogene|January 7, 1998
Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 functionZ Cai, C Capoulade, C Moyret-Lalle, et al.
Tissue Antigens|March 4, 2010
Immune surveillance of human cancer: if the cytotoxic T-lymphocytes play the music, does the tumoral system call the tune?A Hamaï, H Benlalam, F Meslin, et al.
European Cytokine Network|October 1, 1990
TNF alpha enhancement of NK and LAK cell functions induced by high-dose IL-2 in human peripheral blood mononuclear cells from patients pretreated with alpha IFN + IL-2M Favrot, V Combaret, J Y Blay, et al.
Cancer Research|April 15, 1990
Correlation between clinical response to interleukin 2 therapy and sustained production of tumor necrosis factorJ Y Blay, M C Favrot, S Negrier, et al.
Bulletin Du Cancer|October 2, 2001
[Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring]S Chouaib, H Echchakir, E Angevin, et al.
Blood|May 30, 1998
Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphomaM Bagot, H Echchakir, F Mami-Chouaib, et al.
Transplantation|March 1, 1992
Serum levels and receptor expression of tumor necrosis factor-alpha following human allogeneic and autologous bone marrow transplantationE Robinet, A Ibrahim, A Truneh, et al.
European Journal of Immunology|February 17, 2001
Effect of nuclear factor kappaB inhibition on tumor cell sensitivity to natural killer-mediated cytolytic functionF Mami-Chouaib, M Ameyar, G Dorothée, et al.
Bone Marrow Transplantation|October 6, 2009
Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patientsG Pittari, G Fregni, L Roguet, et al.
Oncogene|September 20, 2006
Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activationA Hamaï, C Richon, F Meslin, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Oncogene|January 7, 1998
Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 functionZ Cai, C Capoulade, C Moyret-Lalle, et al.
Tissue Antigens|March 4, 2010
Immune surveillance of human cancer: if the cytotoxic T-lymphocytes play the music, does the tumoral system call the tune?A Hamaï, H Benlalam, F Meslin, et al.
European Cytokine Network|October 1, 1990
TNF alpha enhancement of NK and LAK cell functions induced by high-dose IL-2 in human peripheral blood mononuclear cells from patients pretreated with alpha IFN + IL-2M Favrot, V Combaret, J Y Blay, et al.
Cancer Research|April 15, 1990
Correlation between clinical response to interleukin 2 therapy and sustained production of tumor necrosis factorJ Y Blay, M C Favrot, S Negrier, et al.
Bulletin Du Cancer|October 2, 2001
[Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring]S Chouaib, H Echchakir, E Angevin, et al.
Blood|May 30, 1998
Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphomaM Bagot, H Echchakir, F Mami-Chouaib, et al.
Transplantation|March 1, 1992
Serum levels and receptor expression of tumor necrosis factor-alpha following human allogeneic and autologous bone marrow transplantationE Robinet, A Ibrahim, A Truneh, et al.
European Journal of Immunology|February 17, 2001
Effect of nuclear factor kappaB inhibition on tumor cell sensitivity to natural killer-mediated cytolytic functionF Mami-Chouaib, M Ameyar, G Dorothée, et al.
Bone Marrow Transplantation|October 6, 2009
Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patientsG Pittari, G Fregni, L Roguet, et al.
Oncogene|September 20, 2006
Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activationA Hamaï, C Richon, F Meslin, et al.
Pageof 13